Bioresorbable polymer coated drug eluting stent: A model study

Molecular Pharmaceutics

Volumn 9, Issue 7, 2012, Pages 1898-1910

  Rossi, Filippo ^a   Casalini, Tommaso ^a   Raffa, Edoardo ^a   Masi, Maurizio ^a   Perale, Giuseppe ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

controlled drug delivery; mathematical modeling; polymers; stent

Indexed keywords

GLUCOSE; HEPARIN; IOPROMIDE; PACLITAXEL; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYMER; RAPAMYCIN;

ANIMAL EXPERIMENT; AORTA MEDIA; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEGRADATION; DIFFUSION; DRUG ELUTING STENT; DRUG RELEASE; EQUIPMENT DESIGN; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; IN-STENT RESTENOSIS; MATERIAL COATING; MATHEMATICAL MODEL; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELL LINE; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; MODELS, THEORETICAL; MYOCYTES, SMOOTH MUSCLE; PHARMACEUTICAL PREPARATIONS; POLYMERS; REPRODUCIBILITY OF RESULTS;

EID: 84863331135     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200573f     Document Type: Article

References (81)

1. Moon, S.; Na, K.; Yang, S. G. An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis Biomaterials 2011, 32 (14) 3603-3610
2. Xi, T.; Gao, R.; Xu, B.; Chen, L.; Luo, T.; Liu, J.; Wei, Y.; Zhong, S. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents Biomaterials 2010, 31 (19) 5151-8
3. Sousa, J. E.; Costa, J. R., Jr.; Abizaid, A. 10-year follow-up of the first Cypher stent implanted in human: an invasive evaluation with angiography, intravascular ultrasound, and optical coherence tomography JACC Cardiovasc. Interv. 2010, 3 (5) 556-8
4. Sousa, J. E.; Serruys, P. W.; Costa, M. A. New frontiers in cardiology: drug-eluting stents: Part II Circulation 2003, 107 (18) 2383-9
5. Venkatraman, S.; Boey, F. Release profiles in drug-eluting stents: issues and uncertainties J. Controlled Release 2007, 120 (3) 149-60
6. McFadden, E. P.; Stabile, E.; Regar, E.; Cheneau, E.; Ong, A. T.; Kinnaird, T.; Suddath, W. O.; Weissman, N. J.; Torguson, R.; Kent, K. M.; Pichard, A. D.; Satler, L. F.; Waksman, R.; Serruys, P. W. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 2004, 364 (9444) 1519-21
7. Mehilli, J.; Byrne, R. A.; Tiroch, K.; Pinieck, S.; Schulz, S.; Kufner, S.; Massberg, S.; Laugwitz, K. L.; Schomig, A.; Kastrati, A. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J. Am. Coll. Cardiol. 2010, 55 (24) 2710-6
8. Lei, L.; Guo, S. R.; Chen, W. L.; Rong, H. J.; Lu, F. Stents as a platform for drug delivery Expert Opin. Drug Delivery 2011, 8 (6) 813-31
9. Tesfamariam, B. Drug release kinetics from stent device-based delivery systems J. Cardiovasc. Pharmacol. 2008, 51 (2) 118-25
10. Raval, A.; Parikh, J.; Engineer, C. Mechanism and in Vitro Release Kinetic Study of Sirolimus from a Biodegradable Polymeric Matrix Coated Cardiovascular Stent Ind. Eng. Chem. Res. 2011, 50 (16) 9539-9549
11. Lockwood, N. A.; Hergenrother, R. W.; Patrick, L. M.; Stucke, S. M.; Steendam, R.; Pacheco, E.; Virmani, R.; Kolodgie, F. D.; Hubbard, B. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings J. Biomater. Sci., Polym. Ed. 2010, 21 (4) 529-52
12. Cohen-Sela, E.; Chorny, M.; Koroukhov, N.; Danenberg, H. D.; Golomb, G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles J. Controlled Release 2009, 133 (2) 90-5
13. Danenberg, H. D.; Golomb, G.; Groothuis, A.; Gao, J.; Epstein, H.; Swaminathan, R. V.; Seifert, P.; Edelman, E. R. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits Circulation 2003, 108 (22) 2798-804
14. Cohen-Sela, E.; Rosenzweig, O.; Gao, J.; Epstein, H.; Gati, I.; Reich, R.; Danenberg, H. D.; Golomb, G. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis J. Controlled Release 2006, 113 (1) 23-30
15. Haber, E.; Afergan, E.; Epstein, H.; Gutman, D.; Koroukhov, N.; Ben-David, M.; Schachter, M.; Golomb, G. Route of administration-dependent anti-inflammatory effect of liposomal alendronate J. Controlled Release 2010, 148 (2) 226-33
16. Grube, E.; Buellesfeld, L. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease Expert Rev. Med. Device 2006, 3 (6) 731-41
17. Tamai, H.; Igaki, K.; Kyo, E.; Kosuga, K.; Kawashima, A.; Matsui, S.; Komori, H.; Tsuji, T.; Motohara, S.; Uehata, H. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans Circulation 2000, 102 (4) 399-404
18. Ma, X.; Oyamada, S.; Wu, T.; Robich, M. P.; Wu, H.; Wang, X.; Buchholz, B.; McCarthy, S.; Bianchi, C. F.; Sellke, F. W.; Laham, R. In vitro and in vivo degradation of poly(D,L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents J. Biomed. Mater. Res., Part A 2011, 96 (4) 632-8
19. Li, Y.; Bhindi, R.; Khachigian, L. M. Recent developments in drug-eluting stents J. Mol. Med. 2011, 89 (6) 545-53
20. Acharya, G.; Park, K. Mechanisms of controlled drug release from drug-eluting stents Adv. Drug Delivery Rev. 2006, 58 (3) 387-401
21. Sung, H. J.; Meredith, C.; Johnson, C.; Galis, Z. S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis Biomaterials 2004, 25 (26) 5735-5742
22. Scapin, S. M. N.; Silva, D. R. M.; Joazeiro, P. P.; Alberto-Rincon, M. C.; Luciano, R. M.; Duek, E. A. R. Use of triethylcitrate plasticizer in the production of poly-L-lactic acid implants with different degradation times J. Mater. Sci.: Mater. Med. 2003, 14 (7) 635-640
23. Unger, F.; Westedt, U.; Hanefeld, P.; Wombacher, R.; Zimmermann, S.; Greiner, A.; Ausborn, M.; Kissel, T. Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings? J. Controlled Release 2007, 117 (3) 312-21
24. van der Hoeven, B. L.; Pires, N. M.; Warda, H. M.; Oemrawsingh, P. V.; van Vlijmen, B. J.; Quax, P. H.; Schalij, M. J.; van der Wall, E. E.; Jukema, J. W. Drug-eluting stents: results, promises and problems Int. J. Cardiol. 2005, 99 (1) 9-17
25. Virmani, R.; Farb, A.; Guagliumi, G.; Kolodgie, F. D. Drug-eluting stents: caution and concerns for long-term outcome Coronary Artery Dis. 2004, 15 (6) 313-318
26. Stone, G. W.; Ellis, S. G.; Cannon, L.; Mann, J. T.; Greenberg, J. D.; Spriggs, D.; O'Shaughnessy, C. D.; DeMaio, S.; Hall, P.; Popma, J. J.; Koglin, J.; Russell, M. E.; Investigators, T. V. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease-A randomized controlled trial J. Am. Med. Assoc. 2005, 294 (10) 1215-1223
27. Han, D. W.; Jung, D. Y.; Park, J. C.; Cho, H. H.; Hyon, S. H.; Han, D. K. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application J. Biomed. Mater. Res., Part A 2010, 95 (2) 424-33
28. Dzau, V. J.; Braun-Dullaeus, R. C.; Sedding, D. G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat. Med. 2002, 8 (11) 1249-56
29. Levin, A. D.; Vukmirovic, N.; Hwang, C. W.; Edelman, E. R. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (25) 9463-7
30. Martin, D.; Boyle, F. J. Computational structural modelling of coronary stent deployment: a review Comput. Methods Biomech. 2011, 14 (4) 331-348
31. Hossainy, S.; Prabhu, S. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating J. Biomed. Mater. Res., Part A 2008, 87 (2) 487-93
32. Yang, C. M.; Burt, H. A. Drug-eluting stents: Factors governing local pharmacokinetics Adv. Drug Delivery Rev. 2006, 58 (3) 402-411
33. Kiousis, D. E.; Gasser, T. C.; Holzapfel, G. A. A numerical model to study the interaction of vascular stents with human atherosclerotic lesions Ann. Biomed. Eng. 2007, 35 (11) 1857-1869
34. Zahedmanesh, H.; Lally, C. Determination of the influence of stent strut thickness using the finite element method: implications for vascular injury and in-stent restenosis Med. Biol. Eng. Comput. 2009, 47 (4) 385-393
35. Zhao, H. Q.; Jayasinghe, D.; Hossainy, S.; Schwartz, L. B. A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating J. Biomed. Mater. Res., Part A 2012, 100A (1) 120-124
36. Vergara, C.; Zunino, P. Multiscale Boundary Conditions for Drug Release from Cardiovascular Stents Multiscale Model Simul. 2008, 7 (2) 565-588
37. Seidlitz, A.; Nagel, S.; Semmling, B.; Grabow, N.; Martin, H.; Senz, V.; Harder, C.; Sternberg, K.; Schmitz, K. P.; Kroemer, H. K.; Weitschies, W. Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell Eur. J. Pharm. Biopharm. 2011, 78 (1) 36-48
38. Formaggia, L.; Minisini, S.; Zunino, P. Modeling Polymeric Controlled Drug Release and Transport Phenomena in the Arterial Tissue Math. Mod. Methods Appl. Sci. 2010, 20 (10) 1759-1786
39. D'Angelo, C.; Zunino, P.; Porpora, A.; Morlacchi, S.; Migliavacca, F. Model Reduction Strategies Enable Computational Analysis of Controlled Drug Release from Cardiovascular Stents Siam J. Appl. Math. 2011, 71 (6) 2312-2333
40. D'Angelo, C.; Zunino, P. A Numerical Study of the Interaction of Blood Flow and Drug Release from Cardiovascular Stents Numer. Math. Adv. Appl. 2008, 75-82
41. Kagadis, G. C.; Skouras, E. D.; Bourantas, G. C.; Paraskeva, C. A.; Katsanos, K.; Karnabatidis, D.; Nikiforidis, G. C. Computational representation and hemodynamic characterization of in vivo acquired severe stenotic renal artery geometries using turbulence modeling Med. Eng. Phys. 2008, 30 (5) 647-660
42. Kolachalama, V. B.; Tzafriri, A. R.; Arifin, D. Y.; Edelman, E. R. Luminal flow patterns dictate arterial drug deposition in stent-based delivery J. Controlled Release 2009, 133 (1) 24-30
43. Balakrishnan, B.; Dooley, J. F.; Kopia, G.; Edelman, E. R. Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution J. Controlled Release 2007, 123 (2) 100-108
44. Borghi, A.; Foa, E.; Balossino, R.; Migliavacca, F.; Dubini, G. Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix Comput. Methods Biomech. 2008, 11 (4) 367-377
45. Prabhu, S.; Hossainy, S. Modeling of degradation and drug release from a biodegradable stent coating J. Biomed. Mater. Res., Part A 2007, 80A (3) 732-741
46. Tambaca, J.; Kosor, M.; Canic, S.; Paniagua, D. Mathematical Modeling of Vascular Stents Siam J. Appl. Math. 2010, 70 (6) 1922-1952
47. Morlacchi, S.; Keller, B.; Arcangeli, P.; Balzan, M.; Migliavacca, F.; Dubini, G.; Gunn, J.; Arnold, N.; Narracott, A.; Evans, D.; Lawford, P. Hemodynamics and In-stent Restenosis: Micro-CT Images, Histology, and Computer Simulations Ann. Biomed. Eng. 2011, 39 (10) 2615-2626
48. Pant, S.; Bressloff, N. W.; Limbert, G. Geometry parameterization and multidisciplinary constrained optimization of coronary stents Biomech. Model Mech. 2012, 11 (1-2) 61-82
49. Muliana, A.; Rajagopal, K. R. Modeling the response of nonlinear viscoelastic biodegradable polymeric stents Int. J. Solids Struct. 2012, 49 (7-8) 989-1000
50. Lu, L.; Garcia, C. A.; Mikos, A. G. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films J. Biomed. Mater. Res. 1999, 46 (2) 236-44
51. Lao, L. L.; Venkatraman, S. S. Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application J. Biomed. Mater. Res., Part A 2008, 87 (1) 1-7
52. Pan, C. J.; Tang, J. J.; Weng, Y. J.; Wang, J.; Huang, N. Preparation and characterization of rapamycin-loaded PLGA coating stent J. Mater. Sci.: Mater. Med. 2007, 18 (11) 2193-8
53. Jabara, R.; Chronos, N.; Tondato, F.; Conway, D.; Molema, W.; Park, K.; Mabin, T.; King, S.; Robinson, K. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries J. Invasive Cardiol. 2006, 18 (8) 383-90
54. Lao, L. L.; Venkatraman, S. S. Adjustable paclitaxel release kinetics and its efficacy to inhibit smooth muscle cells proliferation J. Controlled Release 2008, 130 (1) 9-14
55. Drachman, D. E.; Edelman, E. R.; Seifert, P.; Groothuis, A. R.; Bornstein, D. A.; Kamath, K. R.; Palasis, M.; Yang, D.; Nott, S. H.; Rogers, C. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months J. Am. Coll. Cardiol. 2000, 36 (7) 2325-32
56. Tan, L. P.; Venkatraman, S. S.; Sung, P. F.; Wang, X. T. Effect of plasticization on heparin release from biodegradable matrices Int. J. Pharm. 2004, 283 (1-2) 89-96
57. Scheller, B.; Speck, U.; Schmitt, A.; Bohm, M.; Nickenig, G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation J. Am. Coll. Cardiol. 2003, 42 (8) 1415-20
58. Marra, D. E.; Simoncini, T.; Liao, J. K. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1) Circulation 2000, 102 (17) 2124-30
59. Pitt, G. C. Biodegradable Polymers and Plastic; Royal Society of Chemistry: London, U.K., 1992.
60. Arosio, P.; Busini, V.; Perale, G.; Moscatelli, D.; Masi, M. A new model of resorbable device degradation and drug release-part I: zero order model Polym. Int. 2008, 57 (7) 912-920
61. Perale, G.; Arosio, P.; Moscatelli, D.; Barri, V.; Muller, M.; Maccagnan, S.; Masi, M. A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model J. Controlled Release 2009, 136 (3) 196-205
62. Grizzi, I.; Garreau, H.; Li, S.; Vert, M. Hydrolytic Degradation of Devices Based on Poly(Dl-Lactic Acid) Size-Dependence Biomaterials 1995, 16 (4) 305-311
63. von Burkersroda, F.; Schedl, L.; Gopferich, A. Why degradable polymers undergo surface erosion or bulk erosion Biomaterials 2002, 23 (21) 4221-4231
64. Alexis, F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] Polym. Int. 2005, 54 (1) 36-46
65. Tsuji, H.; Tezuka, Y. Alkaline and enzymatic degradation of L-lactide copolymers, 1-Amorphous-made films of L-lactide copolymers with D-lactide, glycolide, and epsilon-caprolactone Macromol. Biosci. 2004, 5 (2) 135-148
66. Tsuji, H.; Tezuka, Y.; Yamada, K. Alkaline and enzymatic degradation of L-lactide copolymers. II. Crystallized films of poly(L-lactide-co-D-lactide) and poly(L-lactide) with similar crystallinities J. Polym. Sci., Part B: Polym. Phys. 2005, 43 (9) 1064-1075
67. Numata, K.; Finne-Wistrand, A.; Albertsson, A. C.; Doi, Y.; Abe, H. Enzymatic degradation of monolayer for poly(lactide) revealed by real-time atomic force microscopy: Effects of stereochemical structure, molecular weight, and molecular branches on hydrolysis rates Biomacromolecules 2008, 9 (8) 2180-2185
68. Zhao, Z. X.; Yang, L.; Hu, Y. F.; He, Y.; Wei, J.; Li, S. M. Enzymatic degradation of block copolymers obtained by sequential ring opening polymerization of L-lactide and epsilon-caprolactone Polym. Degrad. Stab. 2007, 92 (10) 1769-1777
69. Holy, C. E.; Dang, S. M.; Davies, J. E.; Shoichet, M. S. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam Biomaterials 1999, 20 (13) 1177-1185
70. Busini, V.; Arosio, P.; Masi, M. Mechanistic modelling of avascular tumor growth and pharmacokinetics influence-Part I Chem. Eng. Sci. 2007, 62 (7) 1877-1886
71. Masaro, L.; Zhu, X. X. Physical models of diffusion for polymer solutions, gels and solids Prog. Polym. Sci. 1999, 24 (5) 731-775
72. Vrentas, J. S.; Vrentas, C. M. Diffusion in glassy polymers J. Polym. Sci., Part B: Polym. Phys. 2003, 41 (8) 785-788
73. Liggins, R. T.; Hunter, W. L.; Burt, H. M. Solid-state characterization of paclitaxel J. Pharm. Sci. 1997, 86 (12) 1458-63
74. Simamora, P.; Alvarez, J. M.; Yalkowsky, S. H. Solubilization of rapamycin Int. J. Pharm. 2001, 213 (1-2) 25-9
75. Kerns, E. H.; Hill, S. E.; Detlefsen, D. J.; Volk, K. J.; Long, B. H.; Carboni, J.; Lee, M. S. Cellular uptake profile of paclitaxel using liquid chromatography tandem mass spectrometry Rapid Commun. Mass Spectrom. 1998, 12 (10) 620-4
76. Gopferich, A. Mechanisms of polymer degradation and erosion Biomaterials 1996, 17 (2) 103-14
77. Casalini, T.; Masi, M.; Perale, G. Drug eluting sutures: a model for in vivo estimations Int. J. Pharm. 2012, 429 (1) 148-157
78. Powell, R. J.; Cronenwett, J. L.; Fillinger, M. F.; Wagner, R. J. Effect of endothelial cells and transforming growth factor-beta 1 on cultured vascular smooth muscle cell growth patterns J. Vasc. Surg. 1994, 20 (5) 787-94
79. Parry, T. J.; Brosius, R.; Thyagarajan, R.; Carter, D.; Argentieri, D.; Falotico, R.; Siekierka, J. Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries Eur. J. Pharmacol. 2005, 524 (1-3) 19-29
80. Giannakakou, P.; Robey, R.; Fojo, T.; Blagosklonny, M. V. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity Oncogene 2001, 20 (29) 3806-3813
81. Yin, M. J.; Yamamoto, Y.; Gaynor, R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I kappa B kinase-beta Nature 1998, 396 (6706) 77-80